TY - JOUR T1 - Graves’ Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy JF - The Journal of Rheumatology JO - J Rheumatol SP - 449 LP - 449 DO - 10.3899/jrheum.080725 VL - 36 IS - 2 AU - JAE IL SHIN AU - MIN JUNG KIM AU - JAE SEUNG LEE Y1 - 2009/02/01 UR - http://www.jrheum.org/content/36/2/449.abstract N2 - We read with interest the letter by van Lieshout, et al1, describing a 70-year-old woman who developed Graves’ disease while being treated with anti-tumor necrosis factor-α (anti-TNF-α; adalimumab) for active rheumatoid arthritis (RA). They suggested an association of autoimmune thyroid disease with various autoimmune diseases including RA, but could not conclude whether there … Address reprint requests to Dr. J.S. Lee, Department of Pediatrics, Yonsei University College of Medicine, 250 Sungsan-Ro, Seodaemun-Ku, 120-752, CPO Box 8044, Seoul, Korea. E-mail: jsyonse{at}yuhs.ac ER -